Agilent Technologies Inc (A)
138.06
+1.70
(+1.24%)
USD |
NYSE |
Apr 26, 12:59
Agilent Technologies SG&A Expense (Quarterly): 396.00M for Jan. 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
January 31, 2024 | 396.00M |
October 31, 2023 | 393.00M |
July 31, 2023 | 407.00M |
April 30, 2023 | 415.00M |
January 31, 2023 | 419.00M |
October 31, 2022 | 422.00M |
July 31, 2022 | 412.00M |
April 30, 2022 | 386.00M |
January 31, 2022 | 417.00M |
October 31, 2021 | 389.00M |
July 31, 2021 | 403.00M |
April 30, 2021 | 420.00M |
January 31, 2021 | 407.00M |
October 31, 2020 | 387.00M |
July 31, 2020 | 347.00M |
April 30, 2020 | 358.00M |
January 31, 2020 | 404.00M |
October 31, 2019 | 385.00M |
July 31, 2019 | 366.00M |
April 30, 2019 | 354.00M |
January 31, 2019 | 355.00M |
October 31, 2018 | 360.00M |
July 31, 2018 | 341.00M |
April 30, 2018 | 341.00M |
January 31, 2018 | 347.00M |
Date | Value |
---|---|
October 31, 2017 | 347.00M |
July 31, 2017 | 308.00M |
April 30, 2017 | 307.00M |
January 31, 2017 | 289.00M |
October 31, 2016 | 321.00M |
July 31, 2016 | 310.00M |
April 30, 2016 | 318.00M |
January 31, 2016 | 304.00M |
October 31, 2015 | 297.00M |
July 31, 2015 | 290.00M |
April 30, 2015 | 292.00M |
January 31, 2015 | 310.00M |
October 31, 2014 | 312.00M |
July 31, 2014 | 285.00M |
April 30, 2014 | 304.00M |
January 31, 2014 | 298.00M |
October 31, 2013 | -246.00M |
July 31, 2013 | 449.00M |
April 30, 2013 | 497.00M |
January 31, 2013 | 484.00M |
October 31, 2012 | 466.00M |
July 31, 2012 | 458.00M |
April 30, 2012 | 452.00M |
January 31, 2012 | 441.00M |
October 31, 2011 | 445.00M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
347.00M
Minimum
Jul 2020
422.00M
Maximum
Oct 2022
394.35M
Average
399.50M
Median
SG&A Expense (Quarterly) Benchmarks
Bio-Rad Laboratories Inc | 207.15M |
Revvity Inc | 251.75M |
Bruker Corp | 211.80M |
Azenta Inc | 78.58M |
Harvard Bioscience Inc | 11.51M |